Disposable Endoscopes Market Size & Share 2025 - 2034

Disposable Endoscopes Market Size

The global disposable endoscopes market was valued at USD 1.9 billion in 2024. The market is expected to reach USD 2.2 billion in 2025 and USD 8.5 billion in 2034, growing at a CAGR of 16.4% during the forecast period. This increasing demand for minimally invasive procedures and rising incidences of gastrointestinal disorders, cancer, and other chronic conditions.
 

Disease conditions associated with colorectal cancer, inflammatory bowel disease (IBD), peptic ulcers, and esophageal disorders have been increasing over the years globally, attributed to a lack of physical activity, unhealthy food choices, and aging. According to a study published in BMJ Journals in 2021, gastrointestinal cancers account for nearly one-third of global cancer-related mortality. Additionally, in 2022, there were over 1.9 million cases of colorectal cancer worldwide, with an age-adjusted incidence rate of 17.8 per 100,000 population.
 

Early diagnosis and frequent monitoring of these diseases often require endoscopic examinations. In such scenarios, single-use endoscopes present a safer, infection-free option as opposed to traditional reusable endoscopes, which greatly minimize the risk of cross-contamination and hospital-acquired infections (HAIs). For instance, a report published by the National Institutes of Health shows that traditional reusable duodenoscopes have a contamination rate of up to 15.2% despite being reprocessed with enhanced techniques. This is mitigated with disposable duodenoscopes whose contamination rates are lower, making them ideal for patients with weakened immune systems, such as those undergoing chemotherapy for cancer, or those suffering from chronic illness where infection needs to be avoided the most.
 

Disposable endoscopes are either rigid or flexible endoscopic devices with diagnostic and therapeutic capabilities, meant for minimally invasive procedures within the body. As the name suggests, unlike reusable endoscopes, a disposable endoscope is intended for one use only and is thrown away following a single use.
 

Disposable Endoscopes Market Trends

Technological advancements associated with disposable endoscopy devices are improving diagnostic accuracy, patient safety, operational efficiency, and furthermore expanding the market.
 

• Modern disposable endoscopes are attaining high-definition imaging, advanced techniques in optics, steerable tips, enhanced illumination, and integrated lighting. This has resulted in these endoscopes providing superior performance to traditional reusable endoscopes. For instance, Ambu’s aScope Single-Use Endoscopes provide high-quality visualization and workflow efficiency, ensuring a sterile device for every procedure.
   
• Moreover, the creation of affordable single-use endoscopes enabled the use of CMOS sensors for real-time, high clarity visualization also stands out as one of the major innovations. Their lack of complex reprocessing, sterilization, or specialized skilled staff does not make these devices highly appealing in low-resource environments such as the emergency department or point-of-care settings.
   
• Additionally, the integration of AI-powered visualization tools, cloud connectivity for data sharing, and wireless transmission further enhances clinical decision-making and supports tele-endoscopy. These innovations not only reduce procedure time and cross-contamination risks but also lower the total cost of ownership in healthcare facilities.
   

Disposable Endoscopes Market Analysis

 

Based on product type, the market is segmented as bronchoscopes, cystoscopes, duodenoscopes, hysteroscopes, laryngoscopes, ureteroscopes, and other product types. The bronchoscopes segment is expected to drive business growth and expand at a CAGR of 17%, reaching over USD 3.1 billion by 2034.
 

• The implementation of disposable bronchoscopes effectively resolves the problem of cross-contamination associated with reusable bronchoscopes. For instance, according to the International Journal of Environmental Research and Public Health, 59% of the assessed bronchoscopes showed a lack of proper microbial cleaning or compliance with reprocessing, indicating high levels of microbial contamination.
   
• Similarly, there is a growing trend among ICU specialists to integrate single-use bronchoscopes for the purposes of enhancing patient safety, mitigating the risk of infections, and keeping patients safer. 
   
• Moreover, the time-consuming nature of reprocessing reusable bronchoscopes makes disposable options more appealing for emergency and trauma situations, where immediate device availability is essential.
   

 

Based on end use, the market is segmented as hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 63.9% in 2024.
 

• The required infrastructure and technology that hospitals possess enable them to perform a high volume of endoscopic procedures on a yearly basis. For instance, according to the American Society of Anesthesiologists, an estimated 6.1 million upper endoscopies are performed in the U.S. each year. With such high procedural demand, healthcare facilities are increasingly pursuing efficient, safe endoscopic solutions and therefore, making the switch to disposable endoscopes, which in comparison to reusable devices, are more cost-effective and do not pose a risk for infection.
   
• One of the primary issues pertaining to reusable endoscopes is cross-contamination or the potential to further increase hospital-acquired infections (HAIs), which is more prevalent in surgical departments. Procedures utilizing disposable endoscopes are generally infection-free free which decreases the chances of acquiring HAIs and therefore are ideal for critical care units.
   

 

The U.S. disposable endoscopes market accounted for USD 895.9 million market revenue in 2024 and is anticipated to grow at a CAGR of 15.3% between 2025 to 2034.
 

 

• The U.S. has a dominant share of the global market due to its high procedural volumes, swift adoption of new medical technologies, and advanced healthcare infrastructure.
   
• The increasing focus on infection control, particularly for hospital-acquired infections, has increased the adoption of disposable endoscopes. Moreover, active support from the FDA along with increasing research and development investment by local firms, has further enhanced market penetration.
   
• The U.S. is also centrally situated for innovation and growth within the market due to the presence of leading manufacturers and favorable reimbursement policies.
   

The Europe disposable endoscopes market accounted for USD 638.2 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The stringent regulatory framework for device sterilization, the shift towards the use of minimally invasive methods, and the concern about cross-contamination benefit the region.
   
• The European healthcare system is steadily incorporating single-use endoscopic devices into the budget for ICU, ENT, and gastroenterology departments.
   
• Additionally, hospital providers are increasingly shifting towards disposable technologies due to national infection control and readmission rate mandates. Such factors increase the adoption of disposable endoscopes, driving the market growth.
   

The Germany disposable endoscopes market is projected to grow remarkably in the coming years.
 

• Germany’s aging population is contributing to a higher burden of chronic diseases, increasing the need for endoscopic procedures. According to Statista, in 2023, Germany had around 23 million people in the 40-59 age bracket, along with 18.9 million individuals aged 65 and over. This is fueling the development of endoscopic technologies, including disposable endoscopes that improve infection control and operational efficiency in healthcare.
   
• Additionally, colorectal cancer remains a major public health concern in Germany. For instance, as per Robert Koch Institute data, 62,544 new cases were registered in the year 2022 which underscores the necessity for prompt detection and diagnosis. The growing popularity of colorectal surgeries has resulted in an upsurge in surgically performed diagnostic procedures which, in turn, has contributed to an increased use of disposable endoscopes as reliable and safe instruments for infection-free diagnostics.
   

The Rest of the World disposable endoscopes market witnessed substantial growth of 19.6% during the analysis period.
 

• The Rest of the World region is witnessing accelerated growth in the market.
   
• In China and Japan, they are increasingly improving their surgical procedures relative to the elderly population, the volume of chronic diseases, and diagnostic devices including disposable endoscopes.
   
• Similarly, Latin America and MEA are experiencing better investment in their healthcare systems, the construction of new hospitals, and globalization, which gives better access to endoscopic devices.
   

Disposable Endoscopes Market Share

The top 3 companies in the market, such as Ambu, Boston Scientific, and Olympus Corporation account for approximately 40% of the market share. These firms maintain their leadership by continuously advancing high-resolution imaging, AI-assisted diagnostics, and miniaturization technologies to enhance procedural efficiency and patient safety.
 

 Additionally, the adoption of cloud-based data sharing and wireless transmission supports tele-endoscopy, making disposable endoscopes more accessible in rural and remote healthcare settings. These companies also focus on cost-effective single-use solutions, reducing the burden of reprocessing and sterilization while minimizing hospital-acquired infections (HAIs). As disposable endoscopes gain traction in hospitals, ambulatory surgical centers, and emergency care, the market continues to expand, driven by regulatory approvals, reimbursement policies, and increasing demand for infection-free procedures.
 

Disposable Endoscopes Market Companies

Prominent players operating in the disposable endoscopes industry include:

• Ambu
• Boston Scientific
• CooperSurgical
• Flexicare
• Hoya Corporation
• HugeMed
• Karl Storz
• OLYMPUS
• Parburch MEDICAL
• RICHARD WOLF
   
• Ambu specializes in single-use endoscopy, revolutionizing the market by eliminating the risk of cross-contamination and reducing hospital-acquired infections (HAIs). Its aScope series provides high-resolution imaging with an intuitive design, making complex reprocessing and sterilization unnecessary while lowering operational costs for healthcare facilities.
   
• Boston Scientific specializes in advanced medical technology, with a strong focus on infection-free endoscopy through its EXALT Model D Single-Use Duodenoscope. This innovation eliminates over 130 manual sterilization steps, drastically reducing infection risks while maintaining high-performance capabilities comparable to reusable duodenoscopes. The company integrates AI-powered visualization tools and cloud-based connectivity, enhancing clinical decision-making and supporting tele-endoscopy in remote settings.
   

Disposable Endoscopes Industry News:

• In February 2022, Ambu announced the FDA clearance of single-use gastroscope and next-generation display unit. This approval allowed the company to enter the gastroscopy segment with a single-use scope, offering advanced technology, portability, and cost-effectiveness compared to reusable endoscopes, and improved the company’s market positioning.
   
• In May 2021, Boston Scientific announced that it has obtained CE Mark approval for its EXALT Model B Single-Use Bronchoscope. This approval helped the company in strengthening its product portfolio and generating enhanced revenue.
   

The disposable endoscopes market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and volume in units from 2021 — 2034 for the following segments:

Market, By Product Type

• Bronchoscopes
• Cystoscopes
• Duodenoscopes
• Hysteroscopes
• Laryngoscopes
• Ureteroscopes
• Other product types

Market, By End Use

• Hospitals
• Ambulatory Surgical Centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• RoW